Hong Ma is based in Hong Kong and specializes in public health policy and stakeholder engagement. Before joining Edelman, she had a decade of experience leading healthcare research and advocacy projects for healthcare organizations and companies in mainland China.
Ms. Ma's work with healthcare companies in the Asia Pacific region includes experience building stakeholder engagement strategies and platforms with leading academic institutions and think tanks to advance innovation eco-systems, promote value-based progressive reimbursement and people-centric healthcare practice. In these roles, Ms. Ma facilitating discussions for industry associations and their executive member companies to establish industry-wide advocacy positions and platforms. She has also directed policy white papers on behalf of clients to key policy makers. Additionally, Ms. Ma has experience representing patient groups focusing on non-communicable diseases and engaging rare diseases communities.
A key member of the Edelman Global Advisory Asia Pacific leadership team, Ms. Ma works closely with Edelman healthcare leaders across the globe, providing strategic counsel focusing on disease awareness campaigns and corporate public health positioning. As a researcher and author in these areas, she published, together with scholars from Peking Union Medical School, in the leading healthcare journal, The Lancet, on the issue of China’s oncology reimbursement implementation program.
Ms. Ma graduated from Peking University with double BAs and holds a MSc from the London School of Economics (LSE). She has also earned academic qualifications in Biostatistics, Data Management, International Relations, and Global Health. Ms. Ma is currently pursuing a Doctorate degree in Public Health at the University of Illinois.